اثربخشی طرحواره درمانی بافتاری بر نشانگان اضطراب و اجتناب تجربی بیماران مبتلا به اختلال اضطراب تعمیم‌یافته

نوع مقاله : مقاله پژوهشی

نویسنده

استاد‌یار، گروه روان‌شناسی، دانشکده علوم تربیتی و روان‌شناسی، دانشگاه بیرجند، بیرجند، ایران.

چکیده

زمینه: هدف پژوهش حاضر تعیین اثربخشی طرحواره درمانی بافتاری بر نشانگان اضطراب و اجتناب تجربی بیماران مبتلا به اختلال اضطراب تعمیم ­یافته بود.
روش: در این مطالعه نیمه ­آزمایشی از طرح پیش ­آزمون-پس­ آزمون تک ­گروهی با دوره پیگیری دو­ماهه استفاده شد. جامعه آماری شامل تمام افراد مبتلا به اختلال اضطراب فراگیر بود که از 1401 تا 1403 به مراکز مشاوره دانشگاه بیرجند و کلینیک همراه همیشگی در شهر بیرجند مراجعه کرده بودند. نمونه مورد نظر نیز شامل 23 نفر از این بیماران بودند که به روش نمو­نه­ گیری هدفمند انتخاب شدند. شرکت­ کنندگان به مدت 16 جلسه (60 دقیقه ­ای) طرحواره درمانی بافتاری فردی را دریافت کردند. برای جمع­ آوری داد­ه ­ها از مصاحبه بالینی ساختاریافته براساس DSM-5 (SCID)، مقیاس کوتاه اختلال اضطراب فراگیر (GAD-7)، پرسشنامه­ های اضطراب بک (BAI) و پذیرش و عمل (AAQ-II) استفاده شد. داده­ها با آزمون تحلیل واریانس مکرر و شاخص تغییر پایا تحلیل شد.
یافته ­ها: نتایج این مطالعه نشان داد که طرحواره درمانی بافتاری به طور معناداری نشانگان اضطراب و اجتناب تجربی را در بیماران مبتلا به اختلال اضطراب تعمیم ­یافته کاهش می­دهد (0/05 >p). شاخص تغییر پایا نیز برای نشانگان اضطراب و اجتناب تجربی بالاتر 1/96 بود. نهایتاً، بهبود نشانه ­ها در دوره پیگیری نیز معنادار بود
(0/05>p).
نتیجه ­گیری: طرحواره درمانی بافتاری در کاهش نشانگان اضطراب و اجتناب تجربی مؤثر است و می­توان از آن به عنوان یک رویکرد درمانی در بهبود بیماران مبتلا به اختلال اضطراب تعمیم­یافته استفاده کرد.

کلیدواژه‌ها

موضوعات

عنوان مقاله [English]

The effectiveness of contextual schema therapy on anxiety symptoms and experiential avoidance in patients with generalized anxiety disorder

نویسنده [English]

  • Mehdi Rezaei
Department of Psychology, Faculty of Educational Sciences and Psychology, University of Birjand, Birjand, Iran.
چکیده [English]

Background: The aim of the present study was to determine the effectiveness of contextual schema therapy on anxiety symptoms and experiential avoidance in patients with generalized anxiety disorder.
Method: This quasi-experimental research employed a single-group pretest-posttest design with a two-month follow-up. The statistical population included all individuals with generalized anxiety disorder who had been referred to the counseling centers of the University of Birjand and Hamrh-E Hamishegi Clinic in Birjand from 2022 to 2024. The sample included 23 patients selected through purposive sampling. Participants received individual contextual schema therapy for 16 sessions (60 minutes). To collect data, The Structured Clinical Interview for DSM-5 (SCID), the Generalized Anxiety Disorder Assessment-7 (GAD-7), the Beck Anxiety Inventory (BAI), and the Acceptance and Action Questionnaire–II (AAQ-II) were used. The data were analyzed using repeated-measures analysis of variance and the Reliable Change Index (RCI).
Results: The results showed that contextual schema therapy reduces anxiety and experiential avoidance symptoms in patients with generalized anxiety disorder significantly (p< 0.05). The Reliable Change Index on anxiety and experiential avoidance symptoms was also significant. Finally, the improvement of symptoms during the follow-up was also significant (p< 0.05).
Conclusion: Contextual schema therapy is effective in reducing anxiety and experiential avoidance symptoms and can be used as a therapeutic approach in improving patients with generalized anxiety disorder.

کلیدواژه‌ها [English]

  • : Experiential avoidance
  • generalized anxiety disorder
  • anxiety
  • contextual schema therapy

مراجع

  1.  

    1. Hajebi A, Motevalian SA, Rahimi-Movaghar A, Sharifi V, Amin-Esmaeili M, Radgoodarzi R, Hefazi M. Major anxiety disorders in Iran: prevalence, sociodemographic correlates and service utilization. BMC psychiatry. 2018;18:1-8. Doi:10.1186/s12888-018-1828-2
    2. Konnopka A, König H. Economic burden of anxiety disorders: a systematic review and meta-analysis. Pharmacoeconomics. 2020;38:25-37. Doi:10.1007/s40273-019-00849-7
    3. Wiebenga JX, Eikelenboom M, Heering HD, van Oppen P, Penninx BW. Suicide ideation versus suicide attempt: Examining overlapping and differential determinants in a large cohort of patients with depression and/or anxiety. Australian & New Zealand Journal of Psychiatry. 2021;55(2):167-79. Doi:10.1177/0004867420951256
    4. Aune T, Beidel DC, Nordahl HM. Is there any difference between DSM-5 performance-only specifier and social anxiety disorder? Results from the Young-HUNT3 study. Journal of Psychopathology and Behavioral Assessment. 2023;45(3):716-30. Doi:10.1007/s10862-023-10054-8
    5. Showraki M, Showraki T, Brown K. Generalized anxiety disorder: revisited. Psychiatric Quarterly. 2020;91:905-14. Doi:10.1007/s11126-020-09747-0
    6. American Psychological Association. Understanding mental disorders: Your guide to DSM-5-TR®: American Psychiatric Pub; 2023. p. 189-209.
    7. Wang Y, Tian J, Yang Q. Experiential Avoidance Process Model: A Review of the Mechanism for the Generation and Maintenance of Avoidance Behavior. Psychiatry and Clinical Psychopharmacology. 2024;34(2):179. Doi:10.5152/pcp.2024.23777
    8. Hayes-Skelton SA, Eustis EH. Experiential avoidance. American Psychiatric Pub: 2020. Doi:10.1037/0000150-007
    9. Dixon MR, Hayes SC, Belisle J. Acceptance and commitment therapy for behavior analysts: A practice guide from theory to treatment: Routledge; 2023. p. 86-99.
    10. Akbari M, Seydavi M, Hosseini ZS, Krafft J, Levin ME. Experiential avoidance in depression, anxiety, obsessive-compulsive related, and posttraumatic stress disorders: A comprehensive systematic review and meta-analysis. Journal of Contextual Behavioral Science. 2022;24:65-78. Doi:10.1016/j.jcbs.2022.03.007
    11. Szuhany KL, Simon NM. Anxiety disorders: a review. Jama. 2022;328(24):2431-45. Doi:10.1001/jama.2022.22744
    12. Cuijpers P, Miguel C, Harrer M, Plessen CY, Ciharova M, Ebert D, Karyotaki E. Cognitive behavior therapy vs. control conditions, other psychotherapies, pharmacotherapies and combined treatment for depression: A comprehensive meta‐analysis including 409 trials with 52,702 patients. World Psychiatry. 2023;22(1):105-15. Doi:10.1002/wps.21069
    13. Rozental A, Andersson G, Carlbring P. In the absence of effects: An individual patient data meta-analysis of non-response and its predictors in internet-based cognitive behavior therapy. Frontiers in Psychology. 2019;10:589. Doi:10.3389/fpsyg.2019.00589
    14. Lorimer B, Kellett S, Nye A, Delgadillo J. Predictors of relapse and recurrence following cognitive behavioural therapy for anxiety-related disorders: a systematic review. Cognitive Behaviour Therapy. 2021;50(1):1-18. Doi:10.1080/16506073.2020.1812709
    15. Alonso J, Lépine J-P. Overview of key data from the European Study of the Epidemiology of Mental Disorders (ESEMeD). Journal of Clinical Psychiatry. 2007;68(2):3-9. https://pubmed.ncbi.nlm.nih.gov/17288501/
    16. Young J, Klosko J, Weishaar M. Schema therapy: A practitioner's guide Guilford Press: New York, NY; 2003 p. 65-83.
    17. de Klerk N, Abma TA, Bamelis LL, Arntz A. Schema therapy for personality disorders: A qualitative study of patients’ and therapists’ perspectives. Behavioural and cognitive psychotherapy. 2017;45(1):31-45. Doi:10.1017/S1352465816000357
    18. Arntz A, Mensink K, Cox WR, Verhoef REJ, van Emmerik AAP, Rameckers SA, et al. Dropout from psychological treatment for borderline personality disorder: a multilevel survival meta-analysis. Psychological Medicine. 2023;53(3):668-86. Doi:10.1017/S0033291722003634
    19. van Dijk SD, Veenstra MS, van den Brink RH, van Alphen SP, Oude Voshaar RC. A systematic review of the heterogeneity of schema therapy. Journal of Personality Disorders. 2023;37(2):233-62. Doi:10.1521/pedi.2023.37.2.262
    20. Roediger E, Stevens BA, Brockman R. Contextual schema therapy: An integrative approach to personality disorders, emotional dysregulation, and interpersonal functioning: New Harbinger Publications; 2018. p. 116-121.
    21. Ruiz FJ, Flórez CL, García-Martín MB, Monroy-Cifuentes A, Barreto-Montero K, García-Beltrán DM, et al. A multiple-baseline evaluation of a brief acceptance and commitment therapy protocol focused on repetitive negative thinking for moderate emotional disorders. Journal of contextual behavioral science. 2018;9:1-14. Doi:10.3389/fpsyg.2020.00356
    22. Stefan S, Stroian P, Fodor L, Matu S, Nechita D, Boldea I, et al. An online contextual schema therapy workshop for social anxiety symptoms–a randomized controlled trial. Journal of Contextual Behavioral Science. 2023;29:67-75. Doi:10.1016/j.jcbs.2023.06.005
    23. Hayati M, Shehni Yailagh M, Keikhosrovani M. Effects of Contextual Schema Therapy on Interpersonal Sensitivity and Coping Self-Efficacy of Socially Anxious Female Adolescents. Journal of Applied Psychological Research. 2023;14(1):99-114. [Persian] Doi:10.22059/japr.2022.351383.644453
    24. Emamzamani Z, Rahimian Boogar I, Mashhadi A. Effectiveness of contextual schema therapy for fear of negative evaluation and fear of positive evaluation in individuals with social anxiety disorder: Single subject design. Psychological Achievements. 2023;10(3):1-6. [Persian] Doi:10.32598/shenakht.10.3.1
    25. Sohrabi M, Bakhtiarpour S, Sohrabi F, Eftekhar Saadi Z, Asgari P. Effect of Contextual Schema Therapy on Body Image and Psychosomatic Symptoms in Individuals with Perfectionism Disorder. Health Education and Health Promotion. 2023;11(4):621-6. Doi:10.58209/hehp.11.4.621
    26. Sayghalzananmashhad N, Mashhadi A, Shareh H. The Effectiveness of Integrated Mindfulness and Schema Group Therapy on Self-Compassion and Early Maladaptive Schemas on Women with Interpersonal Problems. Journal of Clinical Psychology. 2023;15(2):1-13. [Persian] Doi:10.22075/jcp.2023.30465.2628
    27. Stroian PI, David DO, Hora A, Erenler B, Tuominen EW, Vlachantonis K, Žagar T. Feasibility, acceptability and outcomes of a contextual schema therapy-based mobile program for depressive symptoms in adults. Journal of Contextual Behavioral Science. 2024;34:100839. Doi:10.1016/j.jcbs.2024.100839
    28. Osório FL, Loureiro SR, Hallak JEC, Machado‐de‐Sousa JP, Ushirohira JM, Baes CV, et al. Clinical validity and intrarater and test–retest reliability of the Structured Clinical Interview for DSM‐5–Clinician Version (SCID‐5‐CV). Psychiatry and clinical neurosciences. 2019;73(12):754-60. Doi:10.1111/pcn.12931
    29. Shabani A, Masoumian S, Zamirinejad S, Hejri M, Pirmorad T, Yaghmaeezadeh H. Psychometric properties of structured clinical interview for DSM‐5 disorders‐clinician version (SCID‐5‐CV). Brain and behavior. 2021;11(5):e01894. Doi:10.1002/brb3.1894
    30. Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Archives of internal medicine. 2006;166(10):1092-7. Doi:10.1001/archinte.166.10.1092
    31. Naeinian MR, Shaeiri MR, Sharif M, Hadian M. To Study Reliability and Validity for A Brief Measure for Assessing Generalized Anxiety Disorder (GAD-7). Clinical Psychology and Personality. 2011;9(16): 41-50. [Persian] Doi:20.1001.1.23452188.1390.9.1.5.7
    32. Beck AT, Steer RA, Beck JS. Types of self-reported anxiety in outpatients with DSM-III-R anxiety disorders1. Anxiety, stress, and coping. 1993;6(1):43-55. Doi:10.1080/10615809308249531
    33. Khesht-Masjedi MF, Omar Z, Masoleh SMK. Psychometrics properties of the Persian version of Beck Anxiety Inventory in North of Iranian adolescents. International Journal of Educational and Psychological Researches. 2015;1(2):145. [Persian] Doi:10.4103/2395-2296.152233
    34. Bond FW, Hayes SC, Baer RA, Carpenter KM, Guenole N, Orcutt HK, et al. Preliminary psychometric properties of the Acceptance and Action Questionnaire–II: A revised measure of psychological inflexibility and experiential avoidance. Behavior therapy. 2011;42(4):676-688. Doi:10.1016/j.beth.2011.03.007
    35. Abasi E, Fti L, Molodi R, Zarabi H. Psychometric properties of Persian version of acceptance and action questionnaire–II. Psychological Models and Methods. 2012;3(10/Winter 2013):65-80. https://jpmm.marvdasht.iau.ir/article_61.html?lang=en
    36. Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. 1992. Doi:10.1037//0022-006x.59.1.12

     

فایل ها

سابقه مقاله

  • تاریخ دریافت: 17 آذر 1403
  • تاریخ بازنگری: 18 خرداد 1404
  • تاریخ پذیرش: 18 خرداد 1404
  • تاریخ اولین انتشار: 13 خرداد 1405
  • تاریخ انتشار: 01 تیر 1405

هم رسانی

ارجاع به این مقاله

آمار